Diabetes Diagnostics Market Report 2026

Diabetes Diagnostics Market Overview

• Diabetes Diagnostics market size has reached to $27.31 billion in 2025 • Expected to grow to $38.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Higher Prevalence Of Obesity Driving Growth In The Market • Market Trend: Advancements In Early Detection And Management • North America was the largest region in 2025.

What Is Covered Under Diabetes Diagnostics Market?

Diabetes diagnostics refers to the methods and tests used to identify and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. It involves various medical assessments to detect abnormal glucose metabolism and assess the risk or presence of diabetes. Accurate diagnostics aid in early detection, disease management, and treatment planning. The main product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices used to measure blood sugar levels. They work by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These are used for Type I diabetes, Type II diabetes, and gestational diabetes and are used by various end-users, such as hospitals, diagnostic centers, home care settings, and others.

What Is The Diabetes Diagnostics Market Growth Forecast?

The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $38.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in continuous glucose monitoring usage, increasing adoption of homecare diagnostics, technological advancements in biosensors, rising healthcare expenditure, expansion of digital health ecosystems. Major trends in the forecast period include expansion of continuous glucose monitoring adoption, integration of smart and connected diagnostic devices, rising demand for home-based diabetes testing, increased focus on early diabetes screening programs, advancements in non-invasive glucose monitoring.

Global Diabetes Diagnostics Market Segmentation

1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types 2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes 3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users Subsegments: 1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices 3) By Lancets: Single-Use Lancets, Multi-Use Lancets 4) By Test Strips: Standard Test Strips, Smart Test Strips 5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

What Is The Driver Of The Diabetes Diagnostics Market?

The higher prevalence of obesity is expected to propel the growth of the diabetes diagnostics market going forward. Obesity refers to an excessive accumulation of body fat that increases the risk of various health conditions, such as heart disease and diabetes. The higher prevalence of obesity is attributed to factors such as sedentary lifestyles, increased consumption of processed and high-calorie foods, genetic predisposition, and limited physical activity. Diabetes diagnostics support obesity management by identifying insulin resistance and glucose metabolism issues early, enabling timely interventions to prevent weight gain and related health complications. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the higher prevalence of obesity is driving the growth of the diabetes diagnostics industry.

Key Players In The Global Diabetes Diagnostics Market

Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i‑SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

Global Diabetes Diagnostics Market Trends and Insights

Major companies operating in the diabetes diagnostics market are focused on developing innovative products such as gestational diabetes diagnostics tools to expand their product portfolios and meet the growing demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool refers to medical devices or tests used to detect and monitor gestational diabetes in pregnant women, typically involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to assess how well the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched XpressGT RUO kit, a groundbreaking biosensor tool designed for the detection of insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. The kit provides rapid results, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, and is compatible with standard clinical analyzers. This innovation aims to offer early diagnostics, potentially improving outcomes for millions of patients worldwide.

What Are Latest Mergers And Acquisitions In The Diabetes Diagnostics Market?

In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. With this acquisition, Abbott Laboratories will expand its presence in diabetes care, enhance its FreeStyle Libre portfolio, and advance its efforts to develop connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company dedicated to creating innovative solutions for insulin management.

Regional Outlook

North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetes Diagnostics Market?

The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetes Diagnostics Market Report 2026?

The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.